Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung

Gene Therapy

Volumn 13, Issue 5, 2006, Pages 449-456

  Griesenbach, U ^a,b   Boyton, R J ^a   Somerton, L ^a,b   Garcia, S E ^a,b   Ferrari, S ^a,b   Owaki, T ^a,c   Ya Fen, Z ^c   Geddes, D M ^a,b   Hasegawa, M ^c   Altmann, D M ^a   Alton, E W F W ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UK Cystic Fibrosis Gene Therapy Consortium   (United Kingdom)

^c DNAVEC Research Inc   (Japan)

Author keywords

Lung; Sendai virus; T cells; Tolerization

Indexed keywords

BETA GALACTOSIDASE; EPITOPE; GREEN FLUORESCENT PROTEIN; PROTEIN ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HOST RESISTANCE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SENDAI VIRUS; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; IMMUNE TOLERANCE; IMMUNODOMINANT EPITOPES; LUNG; MICE; MICE, INBRED C57BL; SENDAI VIRUS; T-LYMPHOCYTES; VIRAL VACCINES;

ANIMALIA; SENDAI VIRUS;

EID: 33645139296     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302677     Document Type: Article

References (50)

1. Brennan AL, Geddes DM. Bringing new treatment to the bedside in cystic fibrosis. Pediatr Pulmonol 2004; 37: 87-98.
2. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR et al. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 2005; 16: 2154-2167.
3. Kitson C, Angel B, Judd D, Rothery S, Severs NJ, Dewar A et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Therapy 1999; 6: 534-546.
4. Yonemitsu Y, Kitson C, Ferrari S, Farley R, Griesenbach U, Judd D et al. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 2000; 18: 970-973.
5. Griesenbach U, Cassady R, Ferrari S, Fukumura M, Müller C, Schmitt E et al. The nasal epithelium as a factory for systemic protein delivery. Mol Ther 2002; 5: 98-103.
6. Ferrari S, Farley R, Munkonge F, Griesenbach U, Smith SN, You J et al. Recombinant Sendai virus-mediated CFTR cDNA transfer. Mol Ther 2003; 7: S38 (abstr. 94).
7. Ferrari S, Griesenbach U, Shiraki-Iida T, Shu T, Hironaka T, Hou X et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Therapy 2004; 11: 1659-1664.
8. Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection. Br Med Bull 2002; 61: 1-12.
9. Kolb M, Inman M, Margetts PJ, Galt G. Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors. Am J Respir Crit Care Med 2001; 164: 866-872.
10. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1995; 1: 890-893.
11. Chirmule N, Truneh A, Haecker SE, Tazelaar J, Gao G, Raper SE et al. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. J Immunol 1999; 163: 448-455.
12. Ferrari S, Griesenbach U, Geddes DM, Alton E. Immunological hurdles to lung gene therapy. Clin Exp Immunol 2003; 132: 1-8.
13. Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ et al. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999; 73: 9446-9455.
14. Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524-1532.
15. Manning WC, Zhou S, Bland MP, Escobedo JA, Dwarki V. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther 1998; 9: 477-485.
16. Halbert CL, Standaert TA, Wilson CB, Miller AD. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795-9805.
17. Auricchio A, O'Connor E, Weiner D, Gao G, Hildinger M, Wang L et al. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J Clin Invest 2002; 110: 499-504.
18. Kalb TH, Chuang MT, Marom Z, Mayer L. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol 1991; 4: 320-329.
19. Kurosawa S, Myers AC, Chen L, Wang S, Ni J, Plitt JR et al. Expression of the costimulatory molecule B7-H2 (inducible costimulator ligand) by human airway epithelial cells. Am J Respir Cell Mol Biol 2003; 28: 563-573.
20. Mitchison NA. The dosage requirements for immunological paralysis by soluble proteins. Immunology 1968; 15: 509-530.
21. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L et al. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-837.
22. Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 1996; 93: 956-960.
23. Chai JG, James E, Dewchand H, Simpson E, Scott D. Transplantation tolerance induced by intranasal administration of HY peptides. Blood 2004; 103: 3951-3959.
24. Tsitoura DC, DeKruyff RH, Lamb JR, Umetsu DT. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol 1999; 163: 2592-2600.
25. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999; 189: 1885-1894.
26. Oldfield WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: A randomised controlled trial. Lancet 2002; 360: 47-53.
27. Altmann DM, Blyth WA. Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance. J Gen Virol 1985; 66: 1297-1303.
28. Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J Immunol 1995; 155: 947-957.
29. DeMatteo RP, Chu G, Ahn M, Chang E, Barker CF, Markman JF. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 1997; 71: 5330-5335.
30. Cole GA, Hogg TL, Woodland DL. T cell recognition of the immunodominant Sendai virus NP324-332/Kb epitope is focused on the center of the peptide. J Immunol 1995; 155: 2841-2848.
31. Zhong W, Marshall D, Coleclough C, Woodland DL. CD4+ T cell priming accelerates the clearance of Sendai virus in mice, but has a negative effect on CD8+ T cell memory. J Immunol 2002; 164: 3274-3282.
32. Cauley LS, Cookenham T, Miller TB, Adams PS, Vignali KM, Vignali DAA et al. Cutting edge: Virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. J Immunol 2002; 169: 6655-6658.
33. Cole GA, Hogg TL, Woodland DL. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: A single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int Immunol 1994; 6: 1767-1775.
34. Mastrangeli A, Harvey B-G, Yao J, Wolff G, Kovesdi I, Crystal RG et al. 'Sero-switch' adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum Gene Ther 1996; 7: 79-87.
35. Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T et al. Accommodation of foreign genes into the Sendai virus genome: Sizes of inserted genes and viral replication. FEBS Lett 1999; 456: 221-226.
36. Li Ho, Zhu YF, Asakawa M, Kuma H, Hirata T, Ueda Y et al. A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol 2002; 74: 6564-6569.
37. Inoue M, Tokusumi Y, Ban H, Shirakura M, Kanaya T, Yoshizaki M et al. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: Efficient gene transfer with preferable properties. J Gene Med 2004; 6: 1069-1081.
38. St George JA. Gene therapy progress and prospects: Adenoviral vectors. Gene Therapy 2003; 30: 1135-1141.
39. Sarukhan A, Camugli S, Gjata B, von Boehmer H, Danos O, Jooss K. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269-277.
40. Dubois PM, Pihlgren M, Tomkowiak M, Van Mechelen M, Marvel J. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo. J Immunol 1998; 161: 5260-5267.
41. Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer 2002; 94: 406-414.
42. Fields PA, Armstrong E, Hagstrom JN, Arruda VR, Murphy ML, Farrell JP et al. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice. Gene Therapy 2001; 8: 354-361.
43. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): A randomised, double-blind, phase II trial. Lancet 2001; 358: 1749-1753.
44. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17: 51-88.
45. Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 2001; 193: 981-986.
46. Zhong W, Roberts AD, Woodland DL. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. J Immunol 2001; 167: 1379-1386.
47. Hoyne GF, Dallman MJ, Lamb JR. Linked suppression in peripheral T cell tolerance to the house dust mite derived allergen Der p 1. Int Arch Allergy Immunol 1999; 118: 122-124.
48. Nash AA, Ashford NP. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity. Immunology 1982; 45: 761-767.
49. Hussell T, Openshaw PJ. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J Immunol 2000; 165: 7109-7115.
50. Scaria A, Sullivan JA, St George JA, Kaplan JM, Lukason MJ, Morris JE et al. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates. Mol Ther 2000; 2: 505-514.